(Total Views: 430)
Posted On: 10/25/2023 3:33:31 PM
Post# of 151822
So let's move on. We are not under a hold for NASH or mTNBC.
I would personally like to concentrate on looking for partnerships and buyouts and instead of the concentrating the FDA/BP hold for HIV which I think will be lifted soon.
What happened with Leronlimab being trialed in combination with Keytruda (pembrolizumab) in a cancer in partnership with MD Anderson Cancer Center?
I don't see how a hold has any effect on the partnership or buyout if BP is the partner. Would Merck really have a problem lifting the hold? So we don't get top dollar without a hold lift, is that it?
I would personally like to concentrate on looking for partnerships and buyouts and instead of the concentrating the FDA/BP hold for HIV which I think will be lifted soon.
What happened with Leronlimab being trialed in combination with Keytruda (pembrolizumab) in a cancer in partnership with MD Anderson Cancer Center?
I don't see how a hold has any effect on the partnership or buyout if BP is the partner. Would Merck really have a problem lifting the hold? So we don't get top dollar without a hold lift, is that it?
(1)
(0)Scroll down for more posts ▼
